Coverage
-
March 02, 2020
A biotech company found liable for defaming a pharmaceutical executive aiming to gain control of it was denied a new trial Monday by a federal judge who said overwhelming evidence shows the company fabricated the North Carolina businessman's links to fraud.
1 other articles on this case.
View all »